Search Results 701-710 of 16792 for Superior

1. Publications - Benjamin M. Howe, M.D. - Mayo Clinic

   Tibial intraneural ganglion cysts at the superior tibiofibular joint treated with joint resection alone: a proof of concept. Acta Neurochir (Wien). 2023 Sep ...

2. Screening, intervention and restorative therapy services for injured workers - Mayo Clinic

   "When we give high-risk individuals early access to screening, intervention and restorative therapy services, we see a rate of return to work that is superior ...

3. Hemorrhoidal disease: Diagnosis and management - Mayo Clinic

   A meta-analysis of 18 prospective randomized trials published in Diseases of the Colon & Rectum in 2005 found RBL superior to two other conservative medical ...

4. Sports Medicine Research - Throwing and Overhead Athlete Injury

   Diagnosis and treatment of injuries to the biceps and superior labral complex in overhead athletes. Current Reviews in Musculoskeletal Medicine. 2018;11:63 ...

5. AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke - Mayo Clinic

   Objectives - Primary: To test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in patients with cryptogenic ischemic ...

6. Fuchs Clinical Trials - Mayo Clinic Research

   ... superior to the graft success rate with cornea donors with diabetes, to ... superior to the central ECL when corneas from donors with diabetes are used ...

7. Clinical trials - Oncology (Medical)

   The primary hypothesis is that the combination of sacituzumab tirumotecan and pembrolizumab is superior to pembrolizumab alone with respect to OS. All ...

8. A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) - Mayo Clinic

   The primary hypothesis is that V940 plus pembrolizumab is superior to placebo plus pembrolizumab with respect to disease-free survival (DFS) as assessed by the ...

9. Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) - Mayo Clinic

   The primary hypothesis is that the combination of sacituzumab tirumotecan and pembrolizumab is superior to pembrolizumab alone with respect to OS. All ...

10. Body Imaging Fellowship (Florida) - Residencies and Fellowships - Mayo Clinic College of Medicine & Science

    ... superior results. You will be adept at imaging-guided procedures and have experience in performing contrast-enhanced ultrasound. Program history. The Body ...